PET-CT ½ºÄ³³Ê ±â±â ½ÃÀå º¸°í¼­ : À¯Çüº°, ½½¶óÀ̽º ¼öº°, µ¿À§¿ø¼Ò ¹× °ËÃâ±â À¯Çüº°, ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õº°, ¿ëµµº°, Áö¿ªº°(2025-2033³â)
PET-CT Scanner Device Market Report by Type, Slice Count, Isotope and Detector Type, Service Provider, Application, and Region 2025-2033
»óǰÄÚµå : 1701831
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 136 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,130,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,507,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 6,884,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

PET-CT ½ºÄ³³Ê ±â±â ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 23¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö 32¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025-2033³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 3.44%¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸ÁÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº »ýȰ½À°ü º¯È­ ¹× ȯ°æÀû ¿äÀÎÀ¸·Î ÀÎÇÑ ¾Ï ¹ßº´·ü Áõ°¡, ¿µ»ó Áø´ÜÀÇ Ç°Áú, È¿À²¼º, ȯÀÚ ¾ÈÀü¼ºÀ» Çâ»ó½ÃŰ´Â ±â¼ú Çõ½ÅÀÇ ¹ßÀü, °í·É Àα¸ Áõ°¡ µîÀ» ¹è°æÀ¸·Î ¾ÈÁ¤ÀûÀÎ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

PET-CT ½ºÄ³³Ê ±â±â ½ÃÀå ºÐ¼®:

½ÃÀå ¼ºÀå°ú ±Ô¸ð : ÀÇ·á ÀÎÇÁ¶ó °³¼±, ÷´Ü ¿µ»ó ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î ÀÎÇØ ½ÃÀåÀº ²ÙÁØÈ÷ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

±â¼ú ¹ßÀü : ÀΰøÁö´É(AI) ¾Ë°í¸®Áò°ú ¸ÖƼ¸ð´Þ ¿µ»óó¸® ±â´ÉÀÇ ÅëÇÕÀ¸·Î Áø´Ü ´É·ÂÀÌ °­È­µÇ°í ¿öÅ©Ç÷ο찡 °£¼ÒÈ­µÇ¾ú½À´Ï´Ù.

»ê¾÷ ÀÀ¿ë : PET-CT ½ºÄ³³Ê´Â ½ÉÇ÷°ü ¹× ½Å°æ Áúȯ¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù.

Áö¸®Àû µ¿Çâ : ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½Å¼³ º´¿ø, Áø´Ü ¼¾ÅÍ, Àü¹® Ŭ¸®´ÐÀÇ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ±×·¯³ª ºÏ¹Ì´Â Á¶±â Áø´ÜÀÇ ÀÌÁ¡¿¡ ´ëÇÑ °³ÀεéÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ºü¸£°Ô ¼ºÀåÇÏ´Â ½ÃÀåÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

°æÀï »óȲ : ÁÖ¿ä ±â¾÷µéÀº ¿¬±¸°³¹ß(R&D) Ȱµ¿¿¡ ÅõÀÚÇÏ¿© ¿µ»óó¸® ´É·Â, Áø´Ü Á¤È®µµ, ȯÀÚ ÆíÀǼºÀ» Çâ»ó½ÃŲ Çõ½ÅÀûÀÎ PET-CT ½ºÄ³³Ê ±â¼úÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù.

°úÁ¦¿Í ±âȸ : ³ôÀº Ãʱ⠺ñ¿ë µîÀÇ °úÁ¦¿¡ Á÷¸éÇÑ ¹Ý¸é, PET-CT À̹Ì¡ÀÇ Àû¿ë È®´ë¶ó´Â ±âȸµµ ¸ÂÀÌÇϰí ÀÖ½À´Ï´Ù.

ÇâÈÄ Àü¸Á : °³ÀÎÀÇ ÇコÄÉ¾î ´ÏÁî°¡ ÁøÈ­Çϰí ÀÖÀ¸¸ç, PET-CT ½ºÄ³³Ê ±â±â ½ÃÀåÀÇ ¹Ì·¡´Â À¯¸ÁÇÕ´Ï´Ù. ¶ÇÇÑ, ¼ÒÇü ÈÞ´ë¿ë PET-CT ½ºÄ³³ÊÀÇ °³¹ßÀÌ ÁøÇàµÊ¿¡ µû¶ó PoC À̹Ì¡ÀÌ °¡´ÉÇØÁ® ½ÃÀå È®´ë°¡ ±â´ëµË´Ï´Ù.

PET-CT ½ºÄ³³Ê ±â±â ½ÃÀå µ¿Çâ:

¾Ï ȯÀÚ Áõ°¡

PET-CT ½ºÄ³³Ê´Â ¾ÏÀÇ Áø´Ü, º´±â °áÁ¤ ¹× Ä¡·á ¸ð´ÏÅ͸µ¿¡ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, PET-CT À̹Ì¡À» ÅëÇÑ Á¶±â ¹ß°ßÀº Ä¡·áÀÇ È¿°ú¿Í ȯÀÚ ¿¹Èĸ¦ Çâ»ó½Ã۰í, PET-CT ½ºÄ³³ÊÀÇ º¸±Þ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Ä¡·á È¿°ú¿Í ȯÀÚ ¿¹Èĸ¦ °³¼±ÇÏ°í ±× º¸±Þ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀº Áúº´ÀÇ Á¤È®ÇÑ Æ¯¼ºÈ­¿Í °³º°È­µÈ Ä¡·á °èȹÀ» À§ÇØ PET-CT ½ºÄµ¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ °Ë»ç´Â ¾Ï¼¼Æ÷¿¡ ¼±ÅÃÀûÀ¸·Î Èí¼öµÇ´Â ¹æ»ç¼ºÀǾàǰÀ» »ç¿ëÇÏ¿© Á¾¾ç ³» ´ë»ç Ȱµ¿À» ½Ã°¢È­ÇÕ´Ï´Ù. CT ½ºÄµÀº »ó¼¼ÇÑ ÇØºÎÇÐÀû ¿µ»óÀ» Á¦°øÇÏ¿© PET¿¡¼­ °ËÃâµÈ ºñÁ¤»óÀûÀÎ ´ë»ç Ȱµ¿ÀÇ À§Ä¡¸¦ Á¤È®ÇÏ°Ô ÆÄ¾ÇÇÏ´Â µ¥ µµ¿òÀ» ÁÖ¸ç, PET-CT °Ë»ç¿¡¼­ ¾òÀº Á¾ÇÕÀûÀÎ Á¤º¸´Â Á¾¾ç Àü¹®Àǰ¡ ¼ö¼ú, ¹æ»ç¼± Ä¡·á, È­Çпä¹ý, Ç¥ÀûÄ¡·á µî Ä¡·á Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. °áÁ¤Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, PET-CT °Ë»ç´Â ½Å¼ÓÇÑ Ä¡·á ½ÃÀÛÀ» °¡´ÉÇÏ°Ô ÇÏ¿© ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾Ï°ú ½Î¿ì±â À§ÇØ Ã·´Ü Áø´Ü µµ±¸¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» °³¼±ÇØ¾ß ÇÒ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

±â¼ú ¹ßÀü

PET-CT ½ºÄ³³ÊÀÇ ±â¼ú Çõ½ÅÀº ¿µ»ó Áø´ÜÀÇ Ç°Áú, È¿À²¼º ¹× ȯÀÚ ¾ÈÀü¼ºÀ» Çâ»ó½ÃŰ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÃֽŠPET-CT ½ºÄ³³Ê´Â °ø°£ ÇØ»óµµ°¡ ³ô°í, ÀÛÀº º´º¯µµ ¼±¸íÇÏ°Ô ¹¦»çÇÒ ¼ö ÀÖÀ¸¸ç, Á¾¾çÀÇ °ËÃâ ¹× Æ¯¼ºÈ­ÀÇ Á¤È®µµ°¡ Çâ»óµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº Á¶±â Áø´Ü°ú º¸´Ù Á¤È®ÇÑ Ä¡·á °èȹÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ, ÃֽŠPET-CT ½ºÄ³³Ê´Â ½ºÄµ ½Ã°£ÀÌ Âª¾Æ ȯÀÚÀÇ ºÒÆíÇÔÀ» ÁÙÀ̰í ÀÇ·á ÇöÀåÀÇ ¿öÅ©Ç÷οì È¿À²¼ºÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ºü¸¥ À̹ÌÁö ȹµæÀ» ÅëÇØ ÀÓ»óÀÇ´Â ½Ã°£ ³»¿¡ ´õ ¸¹Àº ½ºÄµÀ» ¼öÇàÇÒ ¼ö ÀÖ¾î ȯÀÚ Ã³¸®·®À» ´Ã¸®°í ÀÚ¿ø Ȱ¿ëÀ» °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, PET-CT ±â¼úÀÇ ¹ßÀüÀ¸·Î Áø´Ü È­ÁúÀ» À¯ÁöÇϸ鼭 ¹æ»ç¼±·®À» ÁÙÀÎ ½ºÄ³³Ê°¡ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ºÄ³³Ê´Â ¾ÈÀü¼ºÀ» Çâ»ó½Ã۰í ȯÀÚÀÇ ¹æ»ç¼± ³ëÃâÀ» ÃÖ¼ÒÈ­ÇÏ¿© ¹Ýº¹ÀûÀÎ ¿µ»ó °Ë»ç¿¡ µû¸¥ Àå±âÀûÀÎ ºÎÀÛ¿ëÀÇ À§ÇèÀ» ÁÙÀÔ´Ï´Ù. À̿ʹ º°µµ·Î, È£Èí °ÔÀÌÆÃ ¹× ¸ð¼Ç Æ®·¡Å·°ú °°Àº °í±Þ ¿òÁ÷ÀÓ º¸Á¤ ±â¼úÀ» äÅÃÇÑ PET-CT ½ºÄ³³Ê´Â º¸´Ù ¼±¸íÇÏ°í ¾ÆÆ¼ÆÑÆ® ¾ø´Â À̹ÌÁö¸¦ º¸ÀåÇÕ´Ï´Ù.

³ë·ÉÀα¸ Áõ°¡

Àü ¼¼°è ³ëÀÎ Àα¸ÀÇ Áõ°¡·Î ÀÎÇÑ PET-CT ½ºÄ³³Ê ±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ³ëÀÎÀº ¾Ï, ¾ËÃ÷ÇÏÀ̸Ӻ´, ½ÉÇ÷°üÁúȯ, ±âŸ ¸¸¼ºÁúȯ¿¡ °É¸®±â ½¬¿ö Áúº´À» Á¤È®ÇÏ°Ô °¨ÁöÇÏ°í ¸ð´ÏÅ͸µÇÒ ¼ö Àִ ÷´Ü ±â±â°¡ ÇÊ¿äÇϸç, PET-CT ½ºÄ³³Ê´Â ½ÉÀå ±â´É, ½É±Ù °ü·ù, »ýü ÀÌ¿ë·üÀ» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ¾î ³ëÀΠȯÀÚÀÇ ½ÉÇ÷°üÁúȯÀ» Áø´ÜÇÏ°í °ü¸®ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. µµ¿òÀ» ÁÙ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³ëÈ­´Â ½Å°æ ÅðÇ༺ ÁúȯÀÇ À§Çè Áõ°¡¿Í °ü·ÃÀÌ ÀÖÀ¸¸ç, PET-CT À̹Ì¡Àº ³ú ´ë»ç, ¾Æ¹Ð·ÎÀ̵å Ä§Âø, ½Å°æ ¼ö¿ëü °áÇÕ¿¡ ´ëÇÑ ±ÍÁßÇÑ Áö½ÄÀ» Á¦°øÇÏ¿© ³ëÀÎÀÇ Á¶±â Áø´Ü ¹× Áúº´ ¸ð´ÏÅ͸µÀ» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. À̿ʹ º°µµ·Î, ³ëÀΠȯÀÚ´Â ¿©·¯ °¡Áö ÇÕº´ÁõÀ» °¡Áö°í ÀÖ´Â °æ¿ì°¡ ¸¹¾Æ Á¾ÇÕÀûÀÎ Áø´Ü Æò°¡°¡ ÇÊ¿äÇѵ¥, PET-CT ½ºÄ³³Ê´Â ¸ÖƼ¸ð´Þ À̹Ì¡ ±â´ÉÀ» °®Ãß°í ÀÖ¾î ÇÑ ¹øÀÇ °Ë»ç·Î ¿©·¯ Àå±â ½Ã½ºÅÛÀ» µ¿½Ã¿¡ Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅëÇÕÀû Á¢±Ù ¹æ½ÄÀº Áø´Ü ¿öÅ©Ç÷ο츦 °£¼ÒÈ­ÇÏ°í ³ëÀÎÀÇ º¹ÀâÇÑ °Ç°­ »óŸ¦ °ü¸®ÇÒ ¶§ ÀÓ»óÀû ÀÇ»ç°áÁ¤À» °­È­ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

Á¦5Àå ¼¼°èÀÇ PET-CT ½ºÄ³³Ê ±â±â ½ÃÀå

Á¦6Àå ½ÃÀå ³»¿ª : À¯Çüº°

Á¦7Àå ½ÃÀå ³»¿ª : ½½¶óÀ̽º ¼öº°

Á¦8Àå ½ÃÀå ³»¿ª : µ¿À§¿ø¼Ò ¹× °ËÃâ±â À¯Çüº°

Á¦9Àå ½ÃÀå ³»¿ª : ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õº°

Á¦10Àå ½ÃÀå ³»¿ª : ¿ëµµº°

Á¦11Àå ½ÃÀå ³»¿ª : Áö¿ªº°

Á¦12Àå SWOT ºÐ¼®

Á¦13Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

Á¦15Àå °¡°Ý ºÐ¼®

Á¦16Àå °æÀï ±¸µµ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global PET-CT scanner device market size reached USD 2.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.2 Billion by 2033, exhibiting a growth rate (CAGR) of 3.44% during 2025-2033. The market is experiencing stable growth driven by rising prevalence of cancer due to lifestyle changes and environmental factors, increasing technological innovations that are leading to enhanced imaging quality, efficiency, and patient safety, and the growing geriatric population.

PET-CT Scanner Device Market Analysis:

Market Growth and Size: The market is witnessing steady growth on account of the improving healthcare infrastructure, along with rising investments in advanced imaging technologies.

Technological Advancements: Integration of artificial intelligence (AI) algorithms and multimodal imaging capabilities is augmenting diagnostic capabilities and streamlining workflows.

Industry Applications: PET-CT scanner devices find applications in cardiovascular and neurological disorders.

Geographical Trends: Asia Pacific leads the market, driven by the rising number of new hospitals, diagnostic centers, and specialty clinics. However, North America is emerging as a fast-growing market due to the increasing awareness among individuals about the benefits of early diagnoses.

Competitive Landscape: Key players are investing in research and development (R&D) activities to develop innovative PET-CT scanner technologies with improved imaging capabilities, enhanced diagnostic accuracy, and patient comfort.

Challenges and Opportunities: While the market faces challenges, such as high initial costs, it also encounters opportunities on account of the expanding applications of PET-CT imaging.

Future Outlook: The future of the PET-CT scanner device market looks promising, with the evolving healthcare needs among individuals. Furthermore, the rising development of compact and portable PET-CT scanners will enable PoC imaging, which is anticipated to bolster the market growth.

PET-CT Scanner Device Market Trends:

Rising prevalence of cancer cases

The increasing prevalence of cancer among the masses around the world is propelling the PET-CT scanner device market growth. PET-CT scanners play a pivotal role in cancer diagnosis, staging, and treatment monitoring. Early detection through PET-CT imaging enhances treatment efficacy and patient outcomes, contributing to its widespread adoption. Moreover, healthcare providers are increasingly relying on PET-CT scans for accurate disease characterization and personalized treatment planning. These scans utilize radiopharmaceuticals that are selectively taken up by cancer cells, allowing for the visualization of metabolic activity within tumors. Meanwhile, CT scans provide detailed anatomical images that help precisely locate abnormal metabolic activity detected by PET. The comprehensive information obtained from PET-CT scans aids oncologists in making informed decisions regarding treatment strategies, including surgery, radiation therapy, chemotherapy, and targeted therapies. In addition, PET-CT scans enable prompt initiation of treatment and potentially improve patient outcomes. There is a rise in the need for improved access to advanced diagnostic tools to fight against cancer.

Technological advancements

Innovations in PET-CT scanners assist in enhancing imaging quality, efficiency, and patient safety. Modern PET-CT scanners feature higher spatial resolution that allows for clearer visualization of small lesions and improved accuracy in tumor detection and characterization. This advancement enables earlier diagnosis and more precise treatment planning. Moreover, advanced PET-CT scanners offer shorter scan times that benefit in reducing patient discomfort and enhancing workflow efficiency in healthcare settings. Rapid image acquisition enables clinicians to perform more scans in a time frame, leading to increased patient throughput and improved resource utilization. Furthermore, advancements in PET-CT technology are leading to the development of scanners with lower radiation doses while maintaining diagnostic image quality. These scanners improve safety and reduce the risk of long-term adverse effects associated with repeated imaging studies by minimizing radiation exposure to patients. Apart from this, PET-CT scanners employed with advanced motion correction techniques, such as respiratory gating and motion tracking, ensure sharper and artifact-free images.

Increasing geriatric population

The growing demand for PET-CT scanner devices due to rising geriatric population worldwide is positively influencing the market. Elderly individuals are more susceptible to cancer, Alzheimer's disease, cardiovascular disorders, and other chronic diseases, necessitating advanced devices that detect and monitor diseases accurately. PET-CT scanners enable comprehensive assessment of cardiac function, myocardial perfusion, and viability, aiding in the diagnosis and management of cardiovascular conditions in geriatric patients. Moreover, aging is associated with an increased risk of neurodegenerative disorders. PET-CT imaging provides valuable insights into brain metabolism, amyloid deposition, and neuroreceptor binding that facilitate early diagnosis and disease monitoring in elderly individuals. Apart from this, geriatric patients often have multiple comorbidities, requiring comprehensive diagnostic evaluations. PET-CT scanners offer multimodal imaging capabilities, allowing for simultaneous assessment of multiple organ systems in a single examination. This integrated approach benefits in streamlining diagnostic workflows and enhancing clinical decision-making in managing complex health conditions in the elderly.

PET-CT Scanner Device Industry Segmentation:

Breakup by Type:

Stationary scanners account for the majority of the market share

Breakup by Slice Count:

Medium slice scanner (64 slices) holds the largest market share

Breakup by Isotope and Detector Type:

Flurodeoxyglucose (FDG) represents the leading market segment

Breakup by Service Provider:

Hospitals exhibit a clear dominance in the market

Breakup by Application:

Oncology dominates the market share

Breakup by Region:

Asia Pacific leads the market, accounting for the largest PET-CT scanner device market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific accounted for the largest market share due to the presence of well-established new hospitals, diagnostic centers, and specialty clinics. In addition, the rising prevalence of cancer among individuals in the region is bolstering the market growth.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global PET-CT Scanner Device Market

6 Market Breakup by Type

7 Market Breakup by Slice Count

8 Market Breakup by Isotope and Detector Type

9 Market Breakup by Service Provider

10 Market Breakup by Application

11 Market Breakup by Region

12 SWOT Analysis

13 Value Chain Analysis

14 Porters Five Forces Analysis

15 Price Analysis

16 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â